<DOC>
	<DOCNO>NCT01563458</DOCNO>
	<brief_summary>This trial conduct Europe , North America Oceania . The aim trial evaluate haemostatic efficacy activate recombinant human factor VII subject undergoing orthotopic liver transplantation surgery .</brief_summary>
	<brief_title>Safety Efficacy Activated Recombinant Human Factor VII Patients Undergoing Orthotopic Liver Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<criteria>Scheduled undergo orthotopic liver transplantation Liver disease classify ChildTurcotte ( Pughs modification ) score B C Previous liver transplantation Scheduled multiorgan transplantation Scheduled living relate donor transplantation Present renal insufficiency require dialysis Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>